血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)

Multiplex Assay Kit for Angiotensinogen (AGT) ,etc. by FLIA (Flow Luminescence Immunoassay)

ANHU; SERPINA8; Angiotensin; Renin Substrate; Serpin Peptidase Inhibitor,Clade A,Member 8(Alpha-1 Antiproteinase,Antitrypsin)

(注:单次混测多因子不超过8个指标 )

  • 血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)产品包装(模拟)
  • 血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)产品包装(模拟)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)99-105102
EDTA plasma(n=5)88-9692
heparin plasma(n=5)80-9285

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%

线性

在定值血清及血浆样本内加入适量的血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)99-105%92-105%80-88%91-102%
EDTA plasma(n=5)96-103%92-101%82-101%80-94%
heparin plasma(n=5)97-105%95-103%89-102%79-91%

稳定性

经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本准备;
2. 加样(标准品、样本、磁珠)标准品或样本100μL及磁珠10μL,
    37°C酶标板振荡器孵育90分钟;
3. 磁吸甩干,加检测溶液A100μL,37°C酶标板振荡器孵育60分钟;
4. 磁吸洗板3次;
5. 加检测溶液B100μL,37°C振动孵育30分钟;
6. 磁吸洗板3次;
7. 加鞘液100μL,旋涡震荡2分钟后读数。

实验原理

将血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)抗体包被于磁珠,制成固相载体,向微孔中分别加入标准品或标本以及磁珠,其中的血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)与连接于固相载体上的抗体结合,然后加入生物素化的血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)抗体,将未结合的生物素化抗体洗净后,加入PE标记的亲和素,再次彻底洗涤后即可上机读数。MFI值和样品中的血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)呈正相关。

赠品

相关产品

编号适用物种:Rattus norvegicus (Rat,大鼠)应用(仅供研究使用,不用于临床诊断!)
APA797Ra61血管紧张素原(AGT)活性蛋白Cell culture; Activity Assays.
RPA797Ra01血管紧张素原(AGT)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
EPA797Ra61血管紧张素原(AGT)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA797Ra01血管紧张素原(AGT)多克隆抗体WB; IHC; ICC; IP.
LAA797Ra71血管紧张素原(AGT)多克隆抗体(生物素标记)WB; IHC; ICC.
LAA797Ra81血管紧张素原(AGT)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
MAA797Ra25血管紧张素原(AGT)单克隆抗体WB; IHC; ICC; IP.
MAA797Ra21血管紧张素原(AGT)单克隆抗体WB; IHC; ICC; IP.
MAA797Ra22血管紧张素原(AGT)单克隆抗体WB; IHC; ICC; IP.
MAA797Ra23血管紧张素原(AGT)单克隆抗体WB; IHC; ICC; IP.
MAA797Ra24血管紧张素原(AGT)单克隆抗体WB; IHC; ICC; IP.
MAA797Ra27血管紧张素原(AGT)单克隆抗体WB; IHC; ICC; IP.
MAA797Ra26血管紧张素原(AGT)单克隆抗体WB; IHC; ICC; IP.
FAA797Ra02抗血管紧张素原(AGT)单克隆抗体Flow cytometry.
SEA797Ra血管紧张素原(AGT)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA797Ra血管紧张素原(AGT)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
KSA797Ra01血管紧张素原(AGT)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
Transplant InternationalElevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?[Wiley: source]
AmyloidThe relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients[PubMed: 22320202]
Pediatric MephrologyUrinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension[PubMed: PMC3661928]
Acta PaediatricaUrinary angiotensinogen as a novel marker of obstructive nephropathy in children[Pubmed: 23772991]
Journal of the Renin-Angiotensin-Aldosterone SystemAssociation between urinary angiotensinogen, hypertension and proteinuria in pregnant women with preeclampsia[Sagepub: Source]
Pediatric NephrologyMP707 CHARACTERISTICS AND OUTCOMES OF CHILDREN WITH AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE COHORT FROM THE ESPN/ERA-EDTA REGISTRY[Oxfordjournals:Source]
journal of human hypertensionRelationship between blood pressure var[PubMed: 26223347]
PLoS OneHigher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis[PubMed: 26098644]
MKAKorelasi pengukuran antropometri dengan tekanan darah dan angiotensinogen plasma pada dewasa[Index.Php: Art]
Journal of Human HypertensionRelationship between blood pressure variability and renal activity of the renin-angiotensin system.[pubmed:26223347]
Acta Pharmacol Sin.Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.[pubmed:27890915]
Journal of Chromatography AApplication of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis[S0021967317311858]
Life SciencesPyrrolidine dithiocarbamate inhibits mouse acute kidney injury induced by diclofenac by targeting oxidative damage, cytokines and NF-κB activity[Pubmed:30036488]
American Journal of Physiology-Renal PhysiologyRole of (Pro) Renin Receptor in Albumin Overload-Induced Nephropathy in Rats[Pubmed:29846109]
Methods in Molecular BiologyQuantitation of Total and Free Thiol Angiotensinogen as a Prognostic Marker for Preeclampsia[Pubmed: 31069778]
J Transl MedMulti-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans[33407555]
Hypertens ResAssociation of Ang-(1¨C7) and des-Arg 9 BK as new biomarkers of obesity and cardiometabolic risk factors in adolescents[33568792]
Physiol Rep(Pro) renin receptor antagonist PRO20 attenuates nephrectomy©\induced nephropathy in rats via inhibition of intrarenal RAS and Wnt/¦Â©\catenin signaling[34057312]
Cancer Cell IntA novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer[34215253]